Tutorials
Alector Inc logo

Alector Inc

$ 13.06 +1.73 (+15.27%) 10:08 PM EST
P/E:
At Loss
P/B:
4.02
Market Cap:
$ 1.08B
Enterprise V:
$ 256.32M
Volume:
818.05K
Avg Vol (2M):
548.26K
Volume:
818.05K
Market Cap $:
1.08B
PE Ratio:
At Loss
Avg Vol (2-Month):
548.26K
Enterprise Value $:
256.32M
PB Ratio:
4.02
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Alector Inc
NAICS : 325412 SIC : 2834
131 Oyster Point Boulevard, Suite 600, South San Francisco, CA, USA, 94080
Description
Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101.

Financials (Next Earnings Date:2022-11-04 Est.)

ALEC's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ALEC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 227.449
EPS (TTM) ($) -0.42
Beta 1.01
Volatility % 46.72
14-Day RSI 69.06
14-Day ATR ($) 0.782277
20-Day SMA ($) 11.0585
12-1 Month Momentum % -59.29
52-Week Range ($) 7.5 - 29.3
Shares Outstanding (Mil) 82.33

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Alector Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More